Access cutting-edge proc treatment through this clinical trial at a research site in Sarasota. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Sarasota location
Preparing your pre-screening questions…
Access proc specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related proc treatment provided free
Check if you qualify for this proc clinical trial in Sarasota, FL
No-Cost Study Care
Local to Sarasota
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
HWK-016-101 is a multicenter, open-label, first-in-human (FIH) Phase 1 study evaluating HWK-016, a targeted antibody-drug conjugate (ADC) in adult participants with advanced or metastatic solid tumors. The study employs a dose escalation and dose expansion design without a control group. The study consists of 2 parts (Part A: monotherapy and Part B: combination therapy with bevacizumab); each part has 2 phases, Phase 1a (dose escalation) and Phase 1b (dose expansion). Enrollment to Part A (Phase 1a and Phase 1b) will include ovarian and endometrial cancers. Enrollment to Part B (Phase 1a and Phase 1b) will include ovarian cancer only. A subsequent protocol amendment may evaluate additional tumor types.
Sponsor: Whitehawk Therapeutics, Inc.
Yes, this clinical trial (NCT07470853) has an active research site in Sarasota, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for proc treatment options in Sarasota, FL, this clinical trial (NCT07470853) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Sarasota research site is actively enrolling participants for this clinical trial. You'll receive care from experienced proc specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all proc clinical trials near you to find additional studies recruiting in your area.
See all ulcerative colitis clinical trials recruiting in Sarasota — not just this study.
Browse Ulcerative Colitis Trials in Sarasota →